id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-D-4311-0002,FDA,FDA-2024-D-4311,Frequently Asked Questions — Developing Potential Cellular and Gene Therapy Products - Draft Guidance for Industry,Other,Guidance,2024-11-19T05:00:00Z,2024,11,2024-11-19T05:00:00Z,2025-02-19T04:59:59Z,2026-01-03T12:58:29Z,,1,0,090000648682824c
FDA-2024-D-4311-0001,FDA,FDA-2024-D-4311,Frequently Asked Questions—Developing Potential Cellular and Gene Therapy Products; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2024-11-19T05:00:00Z,2024,11,2024-11-19T05:00:00Z,,2024-11-19T14:45:46Z,2024-26918,0,0,09000064868276db